Correlation Between Abbott Laboratories and DexCom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and DexCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and DexCom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and DexCom Inc, you can compare the effects of market volatilities on Abbott Laboratories and DexCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of DexCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and DexCom.

Diversification Opportunities for Abbott Laboratories and DexCom

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Abbott and DexCom is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and DexCom Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DexCom Inc and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with DexCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DexCom Inc has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and DexCom go up and down completely randomly.

Pair Corralation between Abbott Laboratories and DexCom

Considering the 90-day investment horizon Abbott Laboratories is expected to generate 0.35 times more return on investment than DexCom. However, Abbott Laboratories is 2.84 times less risky than DexCom. It trades about 0.04 of its potential returns per unit of risk. DexCom Inc is currently generating about -0.02 per unit of risk. If you would invest  10,419  in Abbott Laboratories on August 28, 2024 and sell it today you would earn a total of  1,394  from holding Abbott Laboratories or generate 13.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Abbott Laboratories  vs.  DexCom Inc

 Performance 
       Timeline  
Abbott Laboratories 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
DexCom Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Abbott Laboratories and DexCom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abbott Laboratories and DexCom

The main advantage of trading using opposite Abbott Laboratories and DexCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, DexCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will offset losses from the drop in DexCom's long position.
The idea behind Abbott Laboratories and DexCom Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine